Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Diclofenac Sodium 10%/Lidocaine 10%/Cyclobenzaprine HCl 1% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This allows for easy and precise application on the skin, providing targeted treatment for conditions such as osteoarthritis, tendinitis, bursitis, fibromyalgia, and neuralgia. The gel-like consistency ensures optimal absorption of the active ingredients.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy's Diclofenac Sodium 10%/Lidocaine 10%/Cyclobenzaprine HCl 1% Topical Gel is a potent compounded formulation designed to address a range of musculoskeletal conditions. This unique blend of medications is specifically formulated to alleviate pain and inflammation associated with conditions such as osteoarthritis, tendinitis, bursitis, fibromyalgia, and neuralgia.
Diclofenac Sodium, a non-steroidal anti-inflammatory drug (NSAID), functions by inhibiting the production of certain chemicals in the body that trigger inflammation and pain. Lidocaine, a local anesthetic, operates by blocking nerve signals in the affected area, thereby providing pain relief. Cyclobenzaprine HCl, a muscle relaxant, works by obstructing nerve impulses that lead to muscle spasms and pain.
This topical gel is dispensed through a pump mechanism, facilitating easy and precise application on the skin for targeted treatment. The gel-like consistency allows for optimal absorption of the active ingredients, enhancing their effectiveness.
However, it is crucial to use this formulation as directed by a healthcare provider. If you have any queries about this formulation or its application for your specific condition, please do not hesitate to contact us at Bayview Pharmacy.
This compounded formulation of Diclofenac Sodium 10%/Lidocaine 10%/Cyclobenzaprine HCl 1% Topical Gel is a targeted treatment for conditions such as Osteoarthritis, Tendinitis, Bursitis, Fibromyalgia, and Neuralgia. The active ingredients in this formulation work synergistically to alleviate symptoms associated with these conditions. Diclofenac Sodium, a non-steroidal anti-inflammatory drug (NSAID), reduces inflammation by inhibiting the production of certain natural substances that cause inflammation. Lidocaine, a local anesthetic, provides pain relief by blocking nerve signals in the affected area. Cyclobenzaprine HCl, a muscle relaxant, further aids in symptom management by blocking nerve impulses or pain sensations sent to the brain.
Patients are advised to apply this gel to the affected area 2-3 times daily or as directed by their healthcare provider. It is crucial to avoid contact with the eyes, nose, and mouth, and to not apply the gel to open wounds or broken skin. Patients should also avoid exposing the treated area to excessive heat or cold. If any side effects such as skin irritation, redness, or burning occur, or if symptoms do not improve or worsen, patients should immediately contact their healthcare provider.
Prescribers should exercise caution when prescribing this medication to patients with a history of gastrointestinal bleeding or ulcers, heart disease, stroke, or kidney disease. Additionally, caution is advised when prescribing this medication to pregnant or breastfeeding patients. If you have any questions about this formulation or its application in treating these disease states, please do not hesitate to reach out.
Diclofenac Sodium 10%/Lidocaine 10%/Cyclobenzaprine HCl 1% Topical Gel is a compounded formulation that combines the therapeutic benefits of three potent medications. This unique blend is designed to alleviate pain and inflammation associated with a variety of conditions such as osteoarthritis, tendinitis, bursitis, fibromyalgia, and neuralgia. The formulation is dispensed as a semisolid gel through a pump mechanism, which allows for easy and precise application on the skin.
Diclofenac Sodium, a non-steroidal anti-inflammatory drug (NSAID), is a key component of this formulation. It works by reducing inflammation and pain, providing relief to the affected area. Lidocaine, a local anesthetic, is another active ingredient in this formulation. It functions by numbing the area, thereby reducing pain and discomfort. The third active ingredient, Cyclobenzaprine HCl, is a muscle relaxant that helps to alleviate muscle spasms and pain.
This topical gel is designed to be applied directly to the affected area, where it is absorbed through the skin to provide targeted treatment. It is crucial to note that this medication should not be applied to broken or irritated skin. Furthermore, it is essential to adhere to the directions on the label and avoid using more than the recommended amount. This formulation is a testament to the potential of compounded medications in providing personalized and targeted treatment options.
This is a compounded formulation of three active ingredients: Diclofenac Sodium, Lidocaine, and Cyclobenzaprine HCl. It is a semisolid formulation that is dispensed through a pump mechanism for easy and precise application on the skin.
The pump mechanism facilitates easy and precise application of the gel on the skin. It ensures that the right amount of gel is dispensed each time, reducing the risk of over or under-dosing.
The gel works by delivering the active ingredients directly to the targeted area through the skin. The active ingredients then work to relieve pain and inflammation.
The gel has a gel-like consistency. It is not too thick or too thin, making it easy to apply and absorb into the skin.
You should apply this gel directly to the affected area as directed by your healthcare provider. Make sure to wash your hands before and after application.
No, you should not use this gel on broken or irritated skin. It is meant for application on intact skin only.
If you accidentally ingest this gel, seek medical help immediately. This gel is meant for topical use only and should not be ingested.
If you are pregnant or breastfeeding, you should consult your healthcare provider before using this gel. The active ingredients may be absorbed into the bloodstream and could potentially affect the baby.
Some potential side effects of this gel include skin irritation, redness, or itching at the application site. If you experience any severe or persistent side effects, you should contact your healthcare provider immediately.
Before using this gel with other medications, you should consult your healthcare provider. Some medications may interact with the active ingredients in this gel, potentially causing adverse effects.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
